SWAFFORD CHARLOTTE A 4
4 · NATIONAL HEALTH INVESTORS INC · Filed Dec 11, 2025
Insider Transaction Report
Form 4
SWAFFORD CHARLOTTE A
Director
Transactions
- Exercise/Conversion
Common Stock
2025-12-09$69.20/sh+25,000$1,730,000→ 135,185 total(indirect: By Trust) - Exercise/Conversion
Common Stock
2025-12-09$54.73/sh+10,000$547,300→ 170,185 total(indirect: By Trust) - Tax Payment
Common Stock
2025-12-09$78.37/sh−62,827$4,923,752→ 127,358 total(indirect: By Trust) - Exercise/Conversion
Stock Options (Right to Buy) 2-25-2021
2025-12-09−25,000→ 0 totalExercise: $69.20From: 2021-02-25Exp: 2026-02-25→ Common Stock (25,000 underlying) - Exercise/Conversion
Stock Option (Right to buy) 2022
2025-12-09−25,000→ 0 totalExercise: $53.41From: 2022-02-25Exp: 2027-02-25→ Common Stock (25,000 underlying) - Exercise/Conversion
Stock Option (Right to Buy) 2023
2025-12-09−10,000→ 0 totalExercise: $54.73From: 2023-02-24Exp: 2028-02-24→ Common Stock (10,000 underlying) - Exercise/Conversion
Stock Option (Right to Buy) 2024
2025-12-09−10,000→ 0 totalExercise: $57.76From: 2024-02-23Exp: 2029-02-23→ Common Stock (10,000 underlying) - Exercise/Conversion
Stock Option (Right to Buy) 2025
2025-12-09−10,000→ 0 totalExercise: $73.34From: 2025-03-03Exp: 2030-03-03→ Common Stock (10,000 underlying)